This inventor holds 1 USPTO granted patent. Top assignee: The Radiochemical Centre Limited. Active years: 1982.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1982
Title: The Innovations of James D Kelly
Introduction
James D Kelly is a notable inventor based in Buckinghamshire, GB. He has made significant contributions to the field of radiochemistry, particularly with his innovative work involving indium-111 preparations. His expertise and dedication to advancing medical imaging technologies have earned him recognition in the scientific community.
Latest Patents
James D Kelly holds a patent for an indium-111 oxine complex composition. This patent describes an indium-111 preparation that comprises a complex of indium-111 with a quinoline compound carrying an 8-hydroxyl group, such as oxine. The preparation is present in an aqueous medium that contains a surface active agent to prevent the complex from binding to the surface of the vessel during autoclaving. Additionally, a buffer is included to improve blood cell labeling efficiency. The surface active agent is preferably non-ionic, such as a polyoxyethylene sorbitan ester of a fatty acid, while the buffer is preferably N-2-hydroxyethylpiperazine-N'-2-ethanesulphonic acid. This innovative approach enhances the effectiveness of indium-111 in medical applications.
Career Highlights
James D Kelly has worked with The Radiochemical Centre Limited, where he has applied his knowledge and skills to develop advanced radiochemical products. His work has contributed to the improvement of diagnostic imaging techniques, which are crucial for patient care in the medical field.
Collaborations
Due to space constraints, the collaborations section will be omitted.
Conclusion
James D Kelly's contributions to the field of radiochemistry, particularly through his patent on indium-111 oxine complex composition, highlight his innovative spirit and commitment to advancing medical technology. His work continues to impact the field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile